Cannabis use patterns at the dawn of US cannabis reform.
Cannabis behaviors
Cannabis preferences
Mode of consumption
US legal Cannabis market
Journal
Journal of cannabis research
ISSN: 2522-5782
Titre abrégé: J Cannabis Res
Pays: England
ID NLM: 101752723
Informations de publication
Date de publication:
07 Jun 2019
07 Jun 2019
Historique:
received:
25
01
2019
accepted:
07
04
2019
entrez:
2
2
2021
pubmed:
7
6
2019
medline:
7
6
2019
Statut:
epublish
Résumé
In the United States (US), three in 10 cannabis users develop cannabis use disorder (CUD). Usage patterns in line with CUD may be associated with socio-economic disadvantage, and other negative effects. Thus, research on CUD is paramount. To provide understanding around CUD, it is necessary to detail granular cannabis usage preferences, as some risk from cannabis use may be mitigated through informed behavioral choices by users. We describe cannabis usage preferences among US Global Drug Survey (GDS) respondents, primarily young men. The cross-sectional web-based GDS (2017) was completed by 8345 US-resident respondents (median age = 23, Interquartile Range 19-32; % male = 75.48) who reported cannabis use. Of those who reported cannabis use in the past year, most (78%) reported consuming their first joint more than an hour after waking, and about half the sample (49%) had their last joint 1-2 h before bed. Cannabis was used for a median of 250 days in the last year (almost daily). Respondents spent a median of four hours a day stoned when cannabis was used. High potency herbal cannabis was the preferred variant by 62% of participants. We suggest that frequent use of cannabis may increase risk of health harms, and highlight the need to mitigate problematic use. With the rapidly developing US cannabis market, possibly problematic usage patterns may indicate potential for CUD especially within young men.
Identifiants
pubmed: 33526080
doi: 10.1186/s42238-019-0003-z
pii: 10.1186/s42238-019-0003-z
pmc: PMC7815050
doi:
Types de publication
Journal Article
Langues
eng
Pagination
5Références
Drug Alcohol Depend. 2013 Jul 1;131(1-2):106-11
pubmed: 23291209
J Neurol Neurosurg Psychiatry. 2012 Nov;83(11):1125-32
pubmed: 22791906
Tob Control. 2016 Mar;25(2):174-80
pubmed: 25361744
Subst Abus. 2013;34(3):298-305
pubmed: 23844962
JAMA Psychiatry. 2017 Jun 1;74(6):579-588
pubmed: 28445557
Drug Alcohol Depend. 2009 Apr 1;101(1-2):8-12
pubmed: 19081202
Drug Alcohol Depend. 2016 Sep 01;166:6-12
pubmed: 27476751
Am J Psychiatry. 2016 Jun 1;173(6):588-99
pubmed: 26940807
JAMA Psychiatry. 2015 Dec;72(12):1235-42
pubmed: 26502112
Drug Alcohol Rev. 2009 Nov;28(6):648-57
pubmed: 19930019
Subst Abuse. 2017 Jun 30;11:1178221817716391
pubmed: 28924351
Schizophr Res. 2016 Apr;172(1-3):211-2
pubmed: 26876313
Drug Alcohol Depend. 2017 Feb 01;171:70-83
pubmed: 28024188
Drug Alcohol Depend. 2016 Aug 01;165:175-80
pubmed: 27346327
Drug Alcohol Depend. 2012 Jan 1;120(1-3):22-7
pubmed: 22099393
Dtsch Arztebl Int. 2012 Jul;109(29-30):495-501
pubmed: 23008748
Addiction. 2007 Jul;102(7):1102-13
pubmed: 17567398
Lancet Psychiatry. 2016 Oct;3(10):954-964
pubmed: 27592339
J Environ Public Health. 2012;2012:989474
pubmed: 22654922
Soc Sci Med. 2004 Jul;59(1):113-27
pubmed: 15087148
Int J Drug Policy. 2010 Nov;21(6):511-3
pubmed: 20451365
Am J Public Health. 2017 Aug;107(8):e1-e12
pubmed: 28644037
Int J Drug Policy. 2016 Oct;36:15-24
pubmed: 27450550
Drug Alcohol Depend. 2017 Sep 1;178:32-38
pubmed: 28624604
Addiction. 2011 Jan;106(1):154-61
pubmed: 20735367
Biol Psychiatry. 2016 Apr 1;79(7):613-9
pubmed: 26903403
Prev Med. 2017 Nov;104:13-23
pubmed: 28705601
Addict Behav. 2014 Oct;39(10):1430-3
pubmed: 24930049
J Toxicol Sci. 2015 Dec;40(6):797-803
pubmed: 26558460